跳至主要内容
临床试验/NCT04433806
NCT04433806已完成不适用

The Feasibility of Primary Care Referrals to Community-based Lifestyle Programs for Management of Obesity

Mayo Clinic2 个研究点 分布在 1 个国家目标入组 23 人开始时间: 2020年9月21日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Mayo Clinic
入组人数
23
试验地点
2
主要终点
Participants enrolled

研究概览

简要总结

The purposes of this study is to evaluate the feasibility of providing a community based referral to Mayo Clinic Employee and Community Health patients for weight loss.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients who are between 18-65 years of age
  • Patients who have a BMI between 25-39.9 kg/m2
  • Ability to provide informed consent
  • Ability to complete the Diabetes Prevention Program including dietary and physical activity recommendations
  • Motivated to lose weight (assessed to be in the preparation or action stage)

排除标准

  • Have used weight loss medications or participated in a weight loss program within the past 30 days.
  • Are currently enrolled in DPP or other ExercisAbilities weight loss programs
  • Are currently taking supplements known to affect weight.
  • Have had weight fluctuations of 20 pounds or more in the past 6 months (EMR check and self-report)
  • Have an active untreated clinically significant psychiatric condition (psychosis, bipolar disorder, or depression)
  • Are currently pregnant or breastfeeding, or are of child-bearing potential and are likely to become pregnant during the study (within the next 4 months following enrollment)
  • Have a history in the past 4 months of any major cardiovascular events including heart valve disease, cardiac arrhythmias, congestive heart failure, acute coronary syndrome, stroke, transient ischemic attack, or peripheral vascular disease
  • Have current uncontrolled hypertension (systolic > 160 mm Hg or diastolic > 95 mm Hg) documented on 2 separate occasions
  • Have clinically significant acute or chronic progressive or unstable neurologic, hepatic, renal, cardiovascular, lymphatic, respiratory, or metabolic disease (such as diabetes) or active cancer or are within 1 year of cancer remission
  • Have a known history of any condition or factor judged by the investigator/study team to preclude participation in the study or which might hinder adherence
  • Have any co-morbidity that is deemed exclusionary at the discretion of the provider.

结局指标

主要结局

Participants enrolled

时间窗: Through study completion, approximately 28 weeks

Total number of participants enrolled

Participants recruited

时间窗: Through study completion, approximately 28 weeks

Total number of participants recruited

Participants accrued

时间窗: Through study completion, approximately 28 weeks

Total number of participants accrued

Participants to withdrawn or terminate study participation

时间窗: Through study completion, approximately 28 weeks

Total number of participants to withdrawn or terminate study participation

次要结局

  • Change in Body Mass Index (BMI)(Baseline, week 16, week 28)
  • Participant satisfaction(At study completion, approximately 28 weeks)
  • Change in weight(Baseline, week 16, week 28)
  • Staff satisfaction(At study completion, approximately 28 weeks)

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Tamim I. Rajjo, M.D.

Principal Investigator

Mayo Clinic

研究点 (2)

Loading locations...

相似试验